BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14671984)

  • 1. A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment.
    Pengo V; Barbero F; Biasiolo A; Pegoraro C; Cucchini U; Iliceto S
    Am J Clin Pathol; 2003 Dec; 120(6):944-7. PubMed ID: 14671984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
    Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement.
    Koertke H; Zittermann A; Minami K; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Morshuis M; Koerfer J; Seifert D; Koerfer R
    Ann Thorac Surg; 2005 Jun; 79(6):1909-14; discussion 1914. PubMed ID: 15919283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial.
    Torella M; Torella D; Chiodini P; Franciulli M; Romano G; De Santo L; De Feo M; Amarelli C; Sasso FC; Salvatore T; Ellison GM; Indolfi C; Cotrufo M; Nappi G
    Am Heart J; 2010 Jul; 160(1):171-8. PubMed ID: 20598989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients-.
    Mori T; Asano M; Ohtake H; Bitoh A; Sekiguchi S; Matsuo Y; Aiba M; Yamada M; Kawada T; Takaba T
    Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):83-7. PubMed ID: 12027793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
    Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
    Parra D; Beckey NP; Stevens GR
    Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement.
    Koertke H; Zittermann A; Wagner O; Ennker J; Saggau W; Sack FU; Cremer J; Huth C; Braccio M; Musumeci F; Koerfer R
    Ann Thorac Surg; 2010 Nov; 90(5):1487-93. PubMed ID: 20971245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
    Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early anticoagulation after mechanical valve implantation, and related complications.
    Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS
    J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of periodontal treatment on oral anticoagulation in patients with heart disease.
    Moreira P; Filho PM; Silva EA; Weksler C; Drable SG; Tura BR; Fonseca Mda G; Cunha AB; Fischer RG
    Rev Port Cardiol; 2007 Oct; 26(10):977-89. PubMed ID: 18232621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulant therapy for heart disease: results in actual cardiology practice.
    Baggio D; Madore F; Lalonde G
    Can J Cardiol; 2000 Feb; 16(2):153-61. PubMed ID: 10694585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.